Revance Therapeutics shares owned by DCF Advisers
Quarter-by-quarter ownership of Revance Therapeutics shares owned by DCF Advisers
from 13F filings
Historical chart of DCF Advisers investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by DCF Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Revance Therapeutics by DCF Advisers
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-06-30 | $387k | 600k | 0.64 |
2024-03-31 | $426k | 600k | 0.71 |